- Home
- CURIW vs FLWS Comparison
CURIW vs FLWS Comparison
Compare CURIW & FLWS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CURIW
- FLWS
- Stock Information
- Founded
- CURIW N/A
- FLWS 1976
- Country
- CURIW United States
- FLWS United States
- Employees
- CURIW 48
- FLWS N/A
- Industry
- CURIW Movies/Entertainment
- FLWS Other Specialty Stores
- Sector
- CURIW Consumer Discretionary
- FLWS Consumer Discretionary
- Exchange
- CURIW Nasdaq
- FLWS Nasdaq
- Market Cap
- CURIW N/A
- FLWS N/A
- IPO Year
- CURIW 2020
- FLWS 1999
- Fundamental
- Price
- CURIW $0.03
- FLWS $7.66
- Analyst Decision
- CURIW
- FLWS Hold
- Analyst Count
- CURIW 0
- FLWS 1
- Target Price
- CURIW N/A
- FLWS $7.50
- AVG Volume (30 Days)
- CURIW N/A
- FLWS 831.8K
- Earning Date
- CURIW N/A
- FLWS 01-30-2025
- Dividend Yield
- CURIW N/A
- FLWS N/A
- EPS Growth
- CURIW N/A
- FLWS N/A
- EPS
- CURIW N/A
- FLWS N/A
- Revenue
- CURIW N/A
- FLWS $1,757,899,000.00
- Revenue This Year
- CURIW N/A
- FLWS N/A
- Revenue Next Year
- CURIW N/A
- FLWS $2.93
- P/E Ratio
- CURIW N/A
- FLWS N/A
- Revenue Growth
- CURIW N/A
- FLWS N/A
- 52 Week Low
- CURIW N/A
- FLWS $6.56
- 52 Week High
- CURIW N/A
- FLWS $11.42
- Technical
- Relative Strength Index (RSI)
- CURIW N/A
- FLWS 41.52
- Support Level
- CURIW N/A
- FLWS $7.97
- Resistance Level
- CURIW N/A
- FLWS $9.12
- Average True Range (ATR)
- CURIW 0.00
- FLWS 0.47
- MACD
- CURIW 0.00
- FLWS -0.05
- Stochastic Oscillator
- CURIW 0.00
- FLWS 24.35
About CURIW CuriosityStream Inc. Warrant
CuriosityStream Inc is a media and entertainment company. It offers premium video programming across the principal categories of factual entertainment, including science, history, society, nature, lifestyle, and technology. Its mission is to provide premium real entertainment that informs, enchants, and inspires. Its product and services are Direct to Consumer Business, Partner Direct Business, Bundled Distribution, Content Licensing, Enterprise Subscriptions, and Others. The majority of the revenue comes from the Direct to direct-to-consumer business.